<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">In addition, remdesivir, favipiravir, ribavirin, chloroquine phosphate and other antiviral drugs are still in ongoing clinical research, and the results remain unpublished. It's worth mentioning that, although clinical evidence is lacking, FDA issued an Emergency Use Authorization (EUA) for emergency use of oral formulations of chloroquine phosphate and hydroxychloroquine sulfate for the treatment of COVID-19.
 <xref rid="bib20" ref-type="bibr">
  <sup>20</sup>
 </xref> Hospital pharmacists should combine the available evidence, fully evaluate patients' own conditions, and use antiviral drugs rationally.
</p>
